TITLE

Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone

PUB. DATE
May 2006
SOURCE
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study on the clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (RA). The study included 508 patients with a history of no previous treatment with a disease-modifying antirheumatic drug (DMARD). It is found that in patients with early RA, initial treatment with prednisone or infliximab in combination with DMARDs resulted in less joint damage and better functional outcome than sequential monotherapy or step-up combination therapy with DMARDs alone.
ACCESSION #
21490795

 

Related Articles

  • Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone: COMMENTARY. York, Michael; Hunter, David J. // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p72 

    The article presents the author's views regarding a study on the clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (RA). Aggressive treatment of early RA has been shown to limit functional disability and radiographic...

  • Assessment of anti-TNF-{alpha} efficacy in rheumatoid arthritis: is 3 months sufficient? J. M. Pocock; J. C. Vasconcelos; A. J. K. Östör // Rheumatology;Jul2008, Vol. 47 Issue 7, p1073 

    Objectives. The optimal therapeutic trial duration of anti-TNF-α therapy is currently unknown. The British Society for Rheumatology (BSR) guidance states that non-response at 3 months warrants re-evaluation of treatment and recommends not to persist beyond 6 months. The National Institute...

  • Rheumatoid arthritis: scientific development from a critical point of view. Schöffel, Norman; Mache, Stefanie; Quarcoo, David; Scutaru, Cristian; Vitzthum, Karin; Groneberg, David A.; Spallek, Michael // Rheumatology International;Feb2010, Vol. 30 Issue 4, p505 

    Rheumatoid arthritis (RA) is classified as a chronic, progressive, systemic autoimmune disorder leading to inflammation, stiffness, defective position and destruction of joints. Finally a complete loss of mobility and functioning can be the result. The fraction of disability varies strongly, for...

  • Measures of outcome in patients with inflammatory arthritis. Palmer, Deborah; El Miedany, Yasser // British Journal of Nursing;9/11/2008, Vol. 17 Issue 16, p1052 

    Background: Musculoskeletal disorders account for 15-20% of general practitioner (GP) consultations and cause significant morbidity and disability. Although rheumatology nursing is regarded as a partnership between the practitioner and patient, it remains a relatively tough task to generate a...

  • Quality of Life in Indian Patients with Rheumatoid Arthritis. Bedi, Gurdesh S.; Gupta, Nikhil; Handa, Rohini; Pal, Hemraj; Pandey, R. M. // Quality of Life Research;Oct2005, Vol. 14 Issue 8, p1953 

    Purpose of Study: Rheumatoid arthritis (RA) is a multisystem disease with various extra-articular manifestations (EAMs). Health-related quality of life (HRQOL) issues are assuming increasing importance in chronic rheumatic diseases like RA. No data on QOL in RA is available from the Indian...

  • Rheumatoid arthritis: Second-line therapy often started too late.  // Geriatrics;Aug1991, Vol. 46 Issue 8, p75 

    This article presents a study, conducted by Theodore Pincus. MD, departments of rheumatology and immunology, Vanderbilt University School of Medicine, Nashville, which recommends that clinicians should consider much earlier than usual interbvention with immunosuppressive agents and other...

  • EFFECTIVENESS AND SAFETY PROFILE OF CYCLOSPORIN A IN RHEUMATOID ARTHRITIS. Shah, Faridullah; Ali, Amjad; Mahmood, Khalid // JPMI: Journal of Postgraduate Medical Institute;2010, Vol. 24 Issue 4, p259 

    Objectives: To describe the effectiveness and safety profile of Cyclosporine A in the treatment of Rheumatoid Arthritis. Methodology: The study was conducted in the department of Medicine, Khyber Teaching Hospital from Sep 98 to Aug 99. There was three months recruitment period i.e. July to...

  • THE CORRELATION BETWEEN FRAMINGHAM RISK SCORE AND THE CLINICAL AND BIOCHEMICAL PARAMETERS THAT MEASURE FUNCTIONAL DISABILITY AND DISEASE ACTIVITY IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS. AMEER, KHALID A.; MOHAMMED, SAMER I. // International Journal of Pharmacy & Pharmaceutical Sciences;2014, Vol. 6 Issue 9, p384 

    Objective: Rheumatoid arthritis (RA) patients have increased morbidity and mortality from premature cardiovascular (CV) disease (CVD). Framingham risk score (FRS) is a simplified coronary prediction tool developed to enable clinicians to assess the risk of a cardiovascular event and to identify...

  • A clinical prediction guide predicted progression to rheumatoid arthritis in undifferentiated arthritis.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p154 

    The article presents the author's view on the study "A prediction rule for the disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions." He contends that the authors have taken a step further to diagnose early rheumatoid arthritis...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics